SCHEMBL1573541

SCHEMBL1573541

Clc1cccc(-c2cccs2)n1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.73
ALDH1A1 P00352 6/20 0.73
HPGD P15428 4/20 0.73
MAPT P10636 4/20 0.73
TDP1 Q9NUW8 3/20 0.73
MEN1 O00255 3/20 0.73
KMT2A Q03164 3/20 0.73
L3MBTL1 Q9Y468 3/20 0.73
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
HSD17B10 Q99714 3/20 0.50
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL498897 0.85 KDM4E (1.00) KDM4EALDH1A1HPGDMAPTTDP1
SCHEMBL11563521 0.76 KDM4E (0.73) KDM4EALDH1A1HPGDMAPTTDP1
SCHEMBL154819 0.76 KDM4E (0.73) KDM4EALDH1A1HPGDMAPTTDP1
SCHEMBL14538334 0.76 KDM4E (0.73) KDM4EALDH1A1HPGDMAPTTDP1
SCHEMBL30492599 0.75 CYP3A4 (0.50) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL1071454 0.75 CYP3A4 (0.50) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL12655980 0.74 KDM4E (0.77) KDM4EALDH1A1HPGDMAPTTDP1
SCHEMBL9438481 0.74 ADORA2A (0.54) KDM4EALDH1A1HPGDMAPTTDP1
SCHEMBL9438558 0.73 KDM4E (0.57) KDM4EALDH1A1HPGDMAPTTDP1
SCHEMBL1536347 0.73 KDM4E (0.64) KDM4EALDH1A1HPGDMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1548005-B1 PROCESS FOR PRODUCING 2-SUBSTITUTED PYRIDINE DERIVATIVE KURARAY CO (JP) 2011-04-13 EP disclosed
US-7560563-B2 Process for producing 2-substituted pyridine derivative KURARAY CO., LTD. (JP) 2009-07-14 US disclosed
US-20060041142-A1 Process for producing 2-substituted pyridine derivative KURARAY CO., LTD. (JP) 2006-02-23 US disclosed
EP-1548005-A1 PROCESS FOR PRODUCING 2-SUBSTITUTED PYRIDINE DERIVATIVE Kuraray Co., Ltd. (JP) 2005-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060041142-A1 Process for producing 2-substituted pyridine derivative IDH2, IDH1, NDUFS5 KDM4E 323/4885ALDH1A1 950/4885HPGD 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.